Skip to Primary Content
Skip to Footer
About
About Mannkind
Our Values
Executive Leadership
Board of Directors
History of Innovation
Newsroom
Products & Pipeline
Products & Pipeline
Pipeline Chart
Clinical Trials
About Clinical Trials
Mannkind Trials
Scientific Advisory Board
Publications
Investors
Investing in Mannkind
Events & Presentations
Corporate Deck & Fact Sheet
Press Releases
SEC Filings
Financial Information
Annual Reports
Quarterly Results
ESG
Stock Information
Historic Price Lookup
Investment Calulator
Ownership Profile
Analyst Coverage
Partners
Partnering with Mannkind
Technosphere
Innholation innovation
BluHale Inhalation
H-Patch
Intelectual property
Careers
Mannkind Careers
Locations
Department
Open Positions
Benefits
Internships & Fellowships
About
Our Values
Executive Leadership
Board of Directors
History of Innovation
Newsroom
Products & Pipeline
Pipeline Chart
Clinical Trials
About Clinical Trials
Mannkind Trials
Scientific Advisory Board
Publications
Investors
Events & Presentations
Corporate Deck & Fact Sheet
Press Releases
SEC Filings
Financial Information
Annual Reports
Quarterly Results
ESG
Stock Information
Historic Price Lookup
Investment Calulator
Ownership Profile
Analyst Coverage
Partners
Technosphere
Innholation innovation
BluHale Inhalation
H-Patch
Intelectual property
Careers
Locations
Department
Open Positions
Benefits
Internships & Fellowships
News & Events
March 17, 2015
Use of V-Go® Insulin Delivery Device in Patients with Sub-optimally Controlled Diabetes Mellitus: A Retrospective Analysis from a Large Specialized Diabetes System
previous post
next post
×